nach oben

Journal of Neuro-Oncology

Erschienen in:

05.12.2017 | Clinical Study

Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection

verfasst von: Nikita Lakomkin, Constantinos G. Hadjipanayis

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Several studies have reported an association between high-volume brain tumor centers and greater rates of routine discharge disposition in the context of better outcomes. However, the relationship between in-hospital complications, discharge destination, and postoperative adverse events (AEs) remains unexplored. The purpose of this study was thus to use a large, prospectively collected database to examine the association between discharge destination, post-discharge complications, readmissions, and reoperations among patients undergoing craniotomy for brain tumor. The 2011–2014 National Surgical Quality Improvement (NSQIP) database was employed to identify all adult patients who underwent a craniotomy for brain tumor resection. Demographics, comorbidities, and perioperative variables were collected for each patient. Univariate statistics with subsequent binary logistic regression analyses were used to explore the relationship between these perioperative factors and postoperative events, including major post-discharge complications, minor post-discharge AEs, readmissions, and return to the operating room (ROR). Significant variables such as demographics, comorbidities, operative time, body mass index, ASA classification and pre-discharge complications were controlled for in each model. Of the 14,854 patients identified, 11,409 (77.9%) were discharged home. After controlling for comorbidities and in-hospital AEs, discharge to skilled rehabilitation was an independent predictor of major post-discharge complications (OR 1.74, 95% CI 1.31–2.30, p < 0.001), minor post-discharge events (OR 1.60, 95% CI 1.07–2.41, p = 0.024), and ROR (OR 1.68, 95% CI 1.27–2.22, p < 0.001). Discharge to a care facility was predictive of major complications (OR 1.51, 95% CI 1.04–2.19, p = 0.030) and ROR (OR 2.02, 95% CI 1.46–2.80, p < 0.001). These factors may be considered in discharge planning and further outcomes studies for patients undergoing resection.

Barker FG, Curry WT, Carter BS (2005) Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro-oncology 7:49–63. https://doi.org/10.1215/S1152851704000146 CrossRefPubMedPubMedCentral

Bekelis K, Bakhoum SF, Desai A et al (2013) Outcome prediction in intracranial tumor surgery: the national surgical quality improvement program 2005–2010. J Neurooncol 113:57–64. https://doi.org/10.1007/s11060-013-1089-3 CrossRefPubMedPubMedCentral

Cabantog AM, Bernstein M (1994) Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci J Can Sci Neurol 21:213–218CrossRef

Cote DJ, Dubois HM, Karhade AV, Smith TR (2016) Venous thromboembolism in patients undergoing craniotomy for brain tumors: a U.S. Nationwide analysis. Semin Thromb Hemost 42:870–876. https://doi.org/10.1055/s-0036-1592306 CrossRefPubMed

Lonjaret L, Guyonnet M, Berard E et al (2016) Postoperative complications after craniotomy for brain tumor surgery. Anaesth Crit Care Pain Med. https://doi.org/10.1016/j.accpm.2016.06.012 PubMed

Mukand JA, Blackinton DD, Crincoli MG et al (2001) Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil 80:346–350CrossRefPubMed

Sawaya R, Hammoud M, Schoppa D et al (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055-1056CrossRefPubMed

Dasenbrock HH, Liu KX, Devine CA et al (2015) Length of hospital stay after craniotomy for tumor a national surgical quality improvement program analysis. Neurosurg Focus 39:E12. https://doi.org/10.3171/2015.10.FOCUS15386 CrossRefPubMed

Barsoum WK, Murray TG, Klika AK et al (2010) Predicting patient discharge disposition after total joint arthroplasty in the United States. J Arthroplasty 25:885–892. https://doi.org/10.1016/j.arth.2009.06.022 CrossRefPubMed

10.

Keswani A, Weiser MC, Shin J et al (2016) Discharge destination after revision total joint arthroplasty: an analysis of post discharge outcomes and placement risk factors. J Arthroplasty 31:1866–1872.e1. https://doi.org/10.1016/j.arth.2016.02.053 CrossRefPubMed

11.

London DA, Vilensky S, O’Rourke C et al (2016) Discharge disposition after joint replacement and the potential for cost savings: effect of hospital policies and surgeons. J Arthroplasty 31:743–748. https://doi.org/10.1016/j.arth.2015.10.014 CrossRefPubMed

12.

Missios S, Bekelis K (2015) Drivers of hospitalization cost after craniotomy for tumor resection: creation and validation of a predictive model. BMC Health Serv Res 15:85. https://doi.org/10.1186/s12913-015-0742-2 CrossRefPubMedPubMedCentral

13.

Bini SA, Fithian DC, Paxton LW et al (2010) Does discharge disposition after primary total joint arthroplasty affect readmission rates? J Arthroplasty 25:114–117. https://doi.org/10.1016/j.arth.2008.11.007 CrossRefPubMed

14.

Curry WT, McDermott MW, Carter BS, Barker FG (2005) Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 102:977–986. https://doi.org/10.3171/jns.2005.102.6.0977 CrossRefPubMed

15.

Trinh VT, Davies JM, Berger MS (2015) Surgery for primary supratentorial brain tumors in the United States, 2000–2009: effect of provider and hospital caseload on complication rates. J Neurosurg 122:280–296. https://doi.org/10.3171/2014.9.JNS131648 CrossRefPubMed

16.

Belmont PJ, Goodman GP, Kusnezov NA et al (2014) Postoperative myocardial infarction and cardiac arrest following primary total knee and hip arthroplasty: rates, risk factors, and time of occurrence. J Bone Joint Surg Am 96:2025–2031. https://doi.org/10.2106/JBJS.N.00153 CrossRefPubMed

17.

Lukasiewicz AM, Grant RA, Basques BA et al (2016) Patient factors associated with 30-day morbidity, mortality, and length of stay after surgery for subdural hematoma: a study of the American college of surgeons national surgical quality improvement program. J Neurosurg 124:760–766. https://doi.org/10.3171/2015.2.JNS142721 CrossRefPubMed

18.

AlHilli MM, Tran CW, Langstraat CL et al (2013) Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients. J Am Coll Surg 217:507–515. https://doi.org/10.1016/j.jamcollsurg.2013.04.036 CrossRefPubMedPubMedCentral

19.

Pattakos G, Johnston DR, Houghtaling PL et al (2012) Preoperative prediction of non-home discharge: a strategy to reduce resource use after cardiac surgery. J Am Coll Surg 214:140–147. https://doi.org/10.1016/j.jamcollsurg.2011.11.003 CrossRefPubMed

20.

Hyder JA, Wakeam E, Habermann EB et al (2014) Derivation and validation of a simple calculator to predict home discharge after surgery. J Am Coll Surg 218:226–236. https://doi.org/10.1016/j.jamcollsurg.2013.11.002 CrossRefPubMed

21.

Oldmeadow LB, McBurney H, Robertson VJ (2003) Predicting risk of extended inpatient rehabilitation after hip or knee arthroplasty. J Arthroplasty 18:775–779CrossRefPubMed

22.

Hansen VJ, Gromov K, Lebrun LM et al (2015) Does the risk assessment and prediction tool predict discharge disposition after joint replacement? Clin Orthop 473:597–601. https://doi.org/10.1007/s11999-014-3851-z CrossRefPubMed

23.

Slover J, Mullaly K, Karia R et al (2017) The use of the risk assessment and prediction tool in surgical patients in a bundled payment program. Int J Surg 38:119–122. https://doi.org/10.1016/j.ijsu.2016.12.038 CrossRefPubMed

24.

Best MJ, Buller LT, Falakassa J, Vecchione D (2015) Risk factors for nonroutine discharge in patients undergoing spinal fusion for intervertebral disc disorders. Iowa Orthop J 35:147–155PubMedPubMedCentral

25.

Eagle KA, Berger PB, Calkins H et al (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary a report of the American college of cardiology/American heart association task force on practice guidelines (committee to Update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 105:1257–1267CrossRefPubMed

26.

Foëx P, Sear JW (2004) The surgical hypertensive patient. Contin Educ Anaesth Crit Care Pain 4:139–143. https://doi.org/10.1093/bjaceaccp/mkh039 CrossRef

27.

Dasenbrock HH, Yan SC, Smith TR et al (2017) Readmission after craniotomy for tumor a national surgical quality improvement program analysis. Neurosurgery 80:551–562. https://doi.org/10.1093/neuros/nyw062 CrossRefPubMed

28.

Coll PP, Crabtree BF, O’Connor PJ, Klenzak S (1994) Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home. Arch Fam Med 3:357–360CrossRefPubMed

29.

Thomas JC, Bridge J, Waterman S et al (1989) Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Amp Hosp Epidemiol 10:106–110. https://doi.org/10.2307/30105108 CrossRef

30.

Sollins HL (2013) Office of inspector general report finds skilled nursing facilities “often” fail to meet care planning and discharge planning requirements. Geriatr Nurs N Y N 34:233–234. https://doi.org/10.1016/j.gerinurse.2013.04.005 CrossRef

31.

Mor V, Intrator O, Feng Z, Grabowski DC (2010) The Revolving door of rehospitalization from skilled nursing facilities. Health Aff 29:57–64. https://doi.org/10.1377/hlthaff.2009.0629 CrossRef

Titel: Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection
verfasst von: Nikita Lakomkin
Constantinos G. Hadjipanayis
Publikationsdatum: 05.12.2017
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2018
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-017-2689-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Spinal ependymomas in NF2: a surgical disease?

Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model

Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics

A time of transition in the Journal of Neuro-Oncology